Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method.

It has been reported that values of tissue-plasma ratios (K(p)) and resulting volume of distribution at steady state (V(ss)) are substantially overpredicted for several highly lipophilic drugs. This effect was observed particularly with the published version of the tissue-composition-based model, which used experimentally determined unbound fraction in plasma (fu(p)) as input for drugs. The reasons for the unreasonably high V(ss) predictions were investigated in this study for 14 highly lipophilic compounds with a log n-octanol-water partition coefficient (log P(ow)) of at least 5.8. Here, we argue that the experimentally determined fu(p) is inaccurate for these compounds, which affected the prediction of K(p) and V(ss). Alternatively, the tissue-plasma ratio of neutral lipids (nl) equivalent was used as the main factor governing K(p), and hence V(ss), in addition to log P(ow). The average fold error of deviation between the predicted and observed human V(ss) is 124 for the published model, whereas it significantly decreased to 1.5 for the proposed model. The sensitivity analysis confirmed the importance of nl content and drug lipophilicity. Overall, this study proposes a generic and simplified tissue-composition-based model for highly lipophilic drugs and chemicals, which is a step forward toward improving prediction of V(ss) into physiologically based pharmacokinetic (PBPK) models.

[1]  L. Berezhkovskiy,et al.  The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations. , 2011, Journal of pharmaceutical sciences.

[2]  L. Miles,et al.  2000 , 2000, RDH.

[3]  A. Leo,et al.  Partition coefficients and their uses , 1971 .

[4]  Sean Ekins,et al.  A hybrid approach to advancing quantitative prediction of tissue distribution of basic drugs in human. , 2011, Toxicology and applied pharmacology.

[5]  Leslie Z. Benet,et al.  Effects of Drug Transporters on Volume of Distribution , 2009, The AAPS Journal.

[6]  Malcolm Rowland,et al.  PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. , 2011, Journal of pharmaceutical sciences.

[7]  K. Krishnan,et al.  Mechanistic Animal-Replacement Approaches for Predicting Pharmacokinetics of Organic Chemicals , 1999 .

[8]  Sun Ku Lee,et al.  Comparison of pharmacokinetic interactions and physiologically based pharmacokinetic modeling of PCB 153 and PCB 126 in nonpregnant mice, lactating mice, and suckling pups. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  L. Berezhkovskiy,et al.  Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. , 2004, Journal of pharmaceutical sciences.

[10]  Malcolm Rowland,et al.  Measurement of Binding of Basic Drugs to Acidic Phospholipids Using Surface Plasmon Resonance and Incorporation of the Data into Mechanistic Tissue Composition Equations to Predict Steady-State Volume of Distribution , 2011, Drug Metabolism and Disposition.

[11]  V. Fiserova-Bergerova,et al.  Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals. , 1984, Drug metabolism reviews.

[12]  Walter Schmitt,et al.  General approach for the calculation of tissue to plasma partition coefficients. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  M. Rowland,et al.  Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. , 2006, Journal of pharmaceutical sciences.

[14]  Wilhelm Huisinga,et al.  Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution , 2007, Journal of Pharmacokinetics and Pharmacodynamics.

[15]  K Krishnan,et al.  Relative lipid content as the sole mechanistic determinant of the adipose tissue:blood partition coefficients of highly lipophilic organic chemicals. , 2000, Chemosphere.

[16]  Patrick Poulin,et al.  Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. , 2002, Journal of pharmaceutical sciences.

[17]  Malcolm Rowland,et al.  PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. , 2011, Journal of pharmaceutical sciences.

[18]  Malcolm Rowland,et al.  Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes , 2007, Pharmaceutical Research.

[19]  M. Pfeffer,et al.  VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial , 2000, Circulation.

[20]  S. Paine,et al.  The Impact of Hepatic Uptake on the Pharmacokinetics of Organic Anions , 2011, Drug Metabolism and Disposition.

[21]  G. Nelson.  The phospholipid composition of plasma in various mammalian species , 1967, Lipids.

[22]  Dion R. Brocks,et al.  Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery , 2008, Nature Reviews Drug Discovery.

[23]  E. Nakashima,et al.  Uptake of basic drugs into rat lung granule fraction in vitro. , 1998, Biological & pharmaceutical bulletin.

[24]  J. DeJongh,et al.  A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans , 1997, Archives of Toxicology.

[25]  L. A. Fenu,et al.  Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs , 2007, Drug Metabolism and Disposition.

[26]  Thomas J. Smith,et al.  Association of the blood/air partition coefficient of 1,3-butadiene with blood lipids and albumin. , 2002, Environmental Health Perspectives.

[27]  S. Haddad,et al.  Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes. , 2011, Journal of pharmaceutical sciences.

[28]  Franco Lombardo,et al.  Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. , 2004, Journal of medicinal chemistry.

[29]  E. Nakashima,et al.  Relationships in the Structure–Tissue Distribution of Basic Drugs in the Rabbit , 1990, Pharmaceutical Research.

[30]  T. Iga,et al.  Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs. , 1984, Journal of pharmaceutical sciences.

[31]  R L Dills,et al.  Inter-individual variability in blood/air partitioning of volatile organic compounds and correlation with blood chemistry. , 1994, Journal of exposure analysis and environmental epidemiology.

[32]  Patrick Poulin,et al.  Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. , 2009, Journal of pharmaceutical sciences.

[33]  C H Pierce,et al.  Interindividual differences in 2H8-toluene toxicokinetics assessed by semiempirical physiologically based model. , 1996, Toxicology and applied pharmacology.

[34]  Franco Lombardo,et al.  Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. , 2002, Journal of medicinal chemistry.

[35]  M. Rowland,et al.  Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. , 2005, Journal of pharmaceutical sciences.

[36]  A. Tsuji,et al.  Determination of Protein Binding of a Highly Lipophilic Drug, Isocarbacyclin Methyl Ester (TEI‐9090), Using a Polydimethylsiloxane‐coated Glass Beads Assay , 1994, The Journal of pharmacy and pharmacology.

[37]  Tudor I. Oprea,et al.  BDDCS Applied to Over 900 Drugs , 2011, The AAPS Journal.

[38]  P. Stoffels,et al.  Focus on itraconazole , 1991 .

[39]  F. Theil,et al.  A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. , 2000, Journal of pharmaceutical sciences.

[40]  Thomas Peyret,et al.  A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. , 2010, Toxicology and applied pharmacology.

[41]  L. Berry,et al.  Species Differences in Distribution and Prediction of Human Vss from Preclinical Data , 2011, Drug Metabolism and Disposition.

[42]  Kannan Krishnan,et al.  Molecular Structure-Based Prediction of the Partition Coefficients of Organic Chemicals for Physiological Pharmacokinetic Models , 1996 .

[43]  Sean Ekins,et al.  Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure , 2007, Pharmaceutical Research.

[44]  Rhys D O Jones,et al.  PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach. , 2011, Journal of pharmaceutical sciences.